Diagnostic testing in the control of tuberculosis di Mark D. Perkins, Afranio L. Kritski

Testo

The Case for Improved Diagnostic Tools to Control Ebola Virus Disease in West Africa and How to Get There. di Arlene C Chua, Jane Cunningham, Francis Moussy, Mark D Perkins, Pierre Formenty

Testo

Comprehensive, Comparative Evaluation of 35 Manual SARS-CoV-2 Serological Assays di Wayne Dimech, Shannon Curley, Lorenzo Subissi, Ute Ströher, Mark D. Perkins, Jane Cunningham

Testo

Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine. di Prithwiraj De, Anita G Amin, Eloise Valli, Mark D Perkins, Michael McNeil, Delphi Chatterjee

Testo

Operational implementation of LED fluorescence microscopy in screening tuberculosis suspects in an urban HIV clinic in Uganda. di Heidi Albert, Lydia Nakiyingi, Joseph Sempa, Olive Mbabazi, Sheena Mukkada, Barnabas Nyesiga, Mark D Perkins, Yukari C Manabe

Testo

Performance of three LED-based fluorescence microscopy systems for detection of tuberculosis in Uganda. di Heidi Albert, Yukari Manabe, George Lukyamuzi, Patrick Ademun, Sheena Mukkada, Barnabas Nyesiga, Moses Joloba, C N Paramasivan, Mark D Perkins

Testo

Performance of the TB-LAMP diagnostic assay in reference laboratories: Results from a multicentre study di Thu Hang Pham, Jonathan Peter, Fernanda C.Q. Mello, Tommy Parraga, Nguyen Thi Ngoc Lan, Pamela Nabeta, Eloise Valli, Tatiana Caceres, Keertan Dheda, Susan E. Dorman, Doris Hillemann, Christen M. Gray, Mark D. Perkins

Testo

Implications of storing urinary DNA from different populations for molecular analyses. di Angela Cannas, Glendah Kalunga, Clare Green, Ludovica Calvo, Patrick Katemangwe, Klaus Reither, Mark D Perkins, Leonard Maboko, Michael Hoelscher, Elizabeth A Talbot, Peter Mwaba, Alimuddin I Zumla, Enrico Girardi, Jim F Huggett, TB trDNA consortium

Testo

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. di Anna Vassall, Sanne van Kampen, Hojoon Sohn, Joy S Michael, K R John, Saskia den Boon, J Lucian Davis, Andrew Whitelaw, Mark P Nicol, Maria Tarcela Gler, Anar Khaliqov, Carlos Zamudio, Mark D Perkins, Catharina C Boehme, Frank Cobelens

Testo

Global disparities in SARS-CoV-2 genomic surveillance di Anderson F. Brito, Elizaveta Semenova, Gytis Dudas, Gabriel W. Hassler, Chaney C. Kalinich, Moritz U. G. Kraemer, Joses Ho, Houriiyah Tegally, George Githinji, Charles N. Agoti, Lucy E. Matkin, Charles Whittaker, Bulgarian SARS-CoV-2 sequencing group, Communicable Diseases Genomics Network (Australia and New Zealand), COVID-19 Impact Project, Danish Covid-19 Genome Consortium, Fiocruz COVID-19 Genomic Surveillance Network, GISAID core curation team, Network for Genomic Surveillance in South Africa (NGS-SA), Swiss SARS-CoV-2 Sequencing Consortium, Benjamin P. Howden, Vitali Sintchenko, Neta S. Zuckerman, Orna Mor, Heather M. Blankenship, Tulio de Oliveira, Raymond T. P. Lin, Marilda Mendonça Siqueira, Paola Cristina Resende, Ana Tereza R. Vasconcelos, Fernando R. Spilki, Renato Santana Aguiar, Ivailo Alexiev, Ivan N. Ivanov, Ivva Philipova, Christine V. F. Carrington, Nikita S. D. Sahadeo, Ben Branda, Céline Gurry, Sebastian Maurer-Stroh, Dhamari Naidoo, Karin J. von Eije, Mark D. Perkins, Maria van Kerkhove, Sarah C. Hill, Ester C. Sabino, Oliver G. Pybus, Christopher Dye, Samir Bhatt, Seth Flaxman, Marc A. Suchard, Nathan D. Grubaugh, Guy Baele, Nuno R. Faria

Testo